Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izae165 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Sara Sila und 24 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital Zagreb, University of Zagreb Medical School, Zagreb, Croatia. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Overweight, Inflammatory Bowel Diseases, Obesity. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
This study aimed to evaluate the effect of overweight and obesity at the start of anti-TNF therapy on treatment response and relapse rate in children with inflammatory bowel disease (IBD).
Methods
This multicenter, retrospective cohort study included 22 IBD centers in 14 countries. Children diagnosed with IBD in whom antitumor necrosis factor (anti-TNF) was introduced were included; those who were overweight/obese were compared with children who were well/undernourished.
Results
Six hundred thirty-seven children (370 [58%] males; mean age 11.5 ± 3.5 years) were included; 140 (22%) were in the overweight/obese group (OG) and 497 (78%) had BMI ≤1 SD (CG). The mean follow-up time was 141 ± 78 weeks (median 117 weeks). There was no difference in the loss of response (LOR) to anti-TNF between groups throughout the follow-up. However, children in OG had more dose escalations than controls. Male sex and lack of concomitant immunomodulators at the start of anti-TNF were risk factors associated with the LOR. There was no difference in the relapse rate in the first year after anti-TNF introduction; however, at the end of the follow-up, the relapse rate was significantly higher in the OG compared with CG (89 [64%] vs 218 [44%], respectively, P < .001). Univariate and multivariate analysis revealed that being overweight/obese, having UC, or being of male sex were factors associated with a higher risk for relapse.
Conclusions
Overweight/obese children with IBD were not at a higher risk of LOR to anti-TNF. Relapse in the first year after anti-TNF was introduced, but risk for relapse was increased at the end of follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Hospital Zagreb, University of Zagreb Medical School, Zagreb, Croatia.
- Pediatric Gastroenterology Unit, Sapienza University-Umberto I Hospital, Rome, Italy.
- Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood, University of Messina, Italy.
- Department of Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children and Young People, Edinburgh, UK.
- Pediatric Gastroenterology and Nutrition Unit, Sheba Medical Center, Tel-HaShomer, The Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Department of Paediatrics, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
ORCID-Profile: Marina Aloi, Ben Kang, Kaija-Leena Kolho, Lorenzo Norsa, Darja Urlep, Iva Hojsak
Zitieren
APA
Sila, S., Aloi, M., Cucinotta, U., Gianolio, L., Granot, M., Hradsky, O., Hussey, S., Kang, B., Karoliny, A., Kolho, K. L., de Laffolie, J., Lega, S., Matar, M., Norsa, L., Omiwole, S., Orlanski-Meyer, E., Palomino, L., Rohani, P., Scarallo, L., …, & Hojsak, I. (2025). Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae165
Vancouver
Sila S, Aloi M, Cucinotta U, Gianolio L, Granot M, Hradsky O, et al. Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae165
BibTeX
@article{Sila2025,
author = {Sila, Sara and Aloi, Marina and Cucinotta, Ugo and Gianolio, Laura and Granot, Maya and Hradsky, Ondrej and Hussey, Séamus and Kang, Ben and Karoliny, Anna and Kolho, Kaija-Leena and de Laffolie, Jan and Lega, Sara and Matar, Manar and Norsa, Lorenzo and Omiwole, Sharon and Orlanski-Meyer, Esther and Palomino, Laura and Rohani, Pejman and Scarallo, Luca and Sladek, Margaret and Sohouli, Mohammad Hassan and Urlep, Darja and Yerushalmy-Feler, Anat and Zifman, Eyal and Hojsak, Iva},
title = {Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izae165}
}
EUVIMED